Transcarent Expands Agentic AI Capabilities in WayFinding Platform

The enhancements are designed to support navigation and clinical guidance by enabling AI agents to manage tasks on behalf of users, both in-person and virtual

San Francisco-based healthtech company Transcarent has announced the addition of new agentic artificial intelligence features to its WayFinding health navigation platform.

The new expansion aims to streamline scheduled assistance, symptom guidance, and personalized support through AI-driven agents.

The enhancements are designed to support navigation and clinical guidance by enabling AI agents to manage tasks on behalf of users, both in-person and virtual.

The updates include voice-activated AI scheduling and advanced symptom-checking functions, aiming to assist members with appointment booking, provider identification, and symptom evaluation.

Further, the platform also incorporates a “Total Recall Memory Engine,” which uses individuals’ preferences, history, and interaction patterns, including factors such as language and location, to anticipate appropriate next steps in care navigation.

In addition, members can use the AI agents to review health symptoms and receive information and guidance on appropriate care options.

As per reports, the symptom-checking functions are informed by safety evaluations developed using data from millions of interactions between patients and clinicians within Transcarent’s affiliated medical groups.

Moreover, Transcarent has also expanded the WayFinding platform to offer personalized care pathways for members.

These pathways are informed by input from clinicians, including doctors, nurses, specialists, and therapists, with AI support coordination.

The platform includes recommendations related to preventive care and appropriate health screenings.

The WayFinding solution, launched in 2024, leverages generative AI to connect members with healthcare resources, while also offering access to human support.

The expanded features are intended to streamline tasks that are commonly encountered when seeking care and benefits information.

Commenting on the new expansion, Glen Tullman, CEO of Transcarent, said, “To lead in the AI space today, you need a combination of vision, capabilities, and the willingness to invest. Our continued product progress and innovation, along with our prioritization of safety, demonstrate that commitment. We’ve officially moved beyond the ‘chat assistant era’ into the ‘agentic action era’ in healthcare.”

Stay tuned for more such updates on Digital Health News